In the News
For press and media inquiries, e-mail press@journeyclinical.com
Featured press:
Business Insider: Our CEO’s Personal Journey with Psychedelics
Insider’s Yeji Jesse Lee sat down for a conversation with Jonathan Sabbagh, the cofounder and CEO of Journey Clinical, a platform that connects therapists to ketamine prescribers. Jonathan shared how psychedelics and ketamine-assisted therapy successfully treated his PTSD and other mental health issues, leading him to found the company.
Articles:
I used psychedelics to treat my PTSD after other treatments failed. My experience using these medicines with therapy led me to found my own company.
Business Insider, February 23, 2023
Union Square Ventures Thesis: Journey Clinical Series A
Union Square Ventures, January 25, 2023
Exclusive: Journey Clinical raises $9M to support psychedelic therapy
Axios, January 24, 2023
7 psychedelics startups that are set to take off, according to the most influential female VCs in the industry
Insider, March 24, 2022
Patients Prefer Their Existing Therapists; Journey Clinical Provides The Ketamine
The Dales Report, February 2, 2022
55 Tech Startups to Bet Your Career on in 2022
Insider, December 16, 2021
Unbundling Psychedelic Therapy
The Trip Report, October 1, 2021
Great News for Psychedelics Companies – Journey Clinical Raised $3M Funding For Mental Health Treatment
The Dales Report, September 30, 2021
Journey Clinical Raises $3M for its Service That Empowers Psychotherapists to Offer Psychedelic Therapy
AlleyWatch, September 30, 2021
How psychedelics changed my life (op-ed by Journey CEO Jonathan Sabbagh)
The Independent, September 28, 2021
Psychedelic Groundbreakers: Journey Clinical
Microdose, September 23, 2021
Turning Everyday Therapist Offices into Ketamine Clinics
Lucid News, September 20, 2021
Journey Clinical raises $3M to allow psychotherapists to offer psychedelic therapies
TechCrunch, September 17, 2021
VCs name the top 15 startups in the psychedelics industry
Insider, August 2, 2021
Millions to gain access to Psychedelic Psychotherapy in bid to fight pandemic induced depression and anxiety
Yahoo! Finance, June 17, 2021
Journey Clinical Launches Ketamine Prescription Service to Empower Independent Psychotherapists
Benzinga, June 11, 2021
Psychedelic healthcare fund Neo Kuma sees early success amid sector growth
Tech.eu, June 3, 2021
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Frontiers in Psychology, March 15, 2021
Podcasts:
Psychedelic-Assisted Psychotherapy Podcast with Jonathan Sabbagh
The Science of Psychotherapy, March 21, 2023
Bear Psychology Radio Show with Jonathan Sabbagh, CEO Journey Clinical and Dr. Anna Baranowsky
Bear Psychology Radio Show, July 2, 2022
Examining Ketamine Therapy with Myriam Barthes, Journey Clinical
Psychedelic Spotlight, June 15, 2022
Empowering the next wave of psychedelic therapists: Journey Clinical
Business Trip, May 23, 2022
Ketamine Assisted Psychotherapy with Jonathan Sabbagh of Journey Clinical
Pyschology Talk Podcast, May 2, 2022
Journey Clinical – How to decentralize treating depression
The New Health Club, January 27, 2022
Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care
Psychedelics Today, January 14, 2022
Webcast: The Future of Psychedelic Medicine, the Role of the Pharmacy
Pharmacy Times, December 17, 2021
Ketamine Therapy and the Pharmacist Webcast
Pharmacy Times, September 24, 2021
Ketamine-Assisted Therapy with Journey Clinical Founder Jonathan Sabbagh
Shrink Rap Radio, July 21, 2021
Jonathan Sabbagh (Journey): Supporting Independent Psychedelic Practitioners
The Pyschedelic Therapy Podcast, December 21, 2020